Marchex (MCHX) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The annual meeting is scheduled for December 16, 2025, with voting on director elections and auditor ratification.
Proxy materials are primarily distributed electronically to reduce costs and environmental impact.
Only holders of record as of October 21, 2025, are eligible to vote, with Class A shares carrying 25 votes each and Class B shares 1 vote each.
Forward-looking statements caution about risks and uncertainties affecting future results.
Voting matters and shareholder proposals
Shareholders will vote to elect five directors and to ratify RSM US LLP as the independent auditor for 2025.
The board recommends voting FOR all director nominees and FOR auditor ratification.
Shareholder proposals for the 2026 meeting must be submitted by July 7, 2026, for inclusion in proxy materials.
Board of directors and corporate governance
The board consists of five members, with three classified as independent under NASDAQ standards.
Board committees include Audit, Compensation, and Nominating and Governance, each with independent members and written charters.
Directors attended at least 75% of meetings in 2024, and independent directors met in executive session four times.
The board conducts annual self-assessments and provides a process for shareholder communications.
Codes of conduct and ethics are in place for all directors, officers, and employees.
Latest events from Marchex
- AI-driven product launches and the Archenia deal set the stage for accelerated growth in 2026.MCHX
Q4 202525 Mar 2026 - Net loss narrowed and adjusted EBITDA improved as revenue is set to grow in Q3.MCHX
Q2 20242 Feb 2026 - Q3 2024 delivered $12.6M revenue, narrowed losses, and set the stage for AI-driven growth in 2025.MCHX
Q3 202417 Jan 2026 - 2025 is set for sequential growth and margin improvement, driven by new AI products and partnerships.MCHX
Q4 202424 Dec 2025 - Annual meeting to elect directors, ratify auditor, and highlight governance and compensation practices.MCHX
Proxy Filing1 Dec 2025 - Annual proxy details director elections, voting proposals, and governance disclosures.MCHX
Proxy Filing1 Dec 2025 - Q1 2025 revenue $11.4M, net loss $2.0M, gross margin 63%, targeting $50M+ run rate.MCHX
Q1 202525 Nov 2025 - Q2 2025 saw revenue dip 3% but net income and operational efficiency improved.MCHX
Q2 202523 Nov 2025 - Q3 revenue fell, but profitability improved and Archenia acquisition aims for accelerated AI growth.MCHX
Q3 202517 Nov 2025